Epalinges
Switzerland
4
2024-05-30
4
2025-01-21
These are the the leading inventors for applications assigned to OPNA BIO SA:
OPNA BIO SA based in Epalinges, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Compounds and methods for CD73 modulation and indications therefor
#2 | 2022-11-10 ✅ Patent 12,116,365 granted on 2024-10-15Heterocyclic compounds and uses thereof
#3 | 2022-05-12 ✅ Patent 11,807,626 granted on 2023-11-07Compounds and methods for CD73 modulation and indications therefor
#4 | 2022-02-24 ✅ Patent 11,628,176 granted on 2023-04-18Combinational drug therapies
Also check out Opna Bio SA's (Epalinges, Switzerland) applicant profile with 6 patent applications submitted.
598133 ⎘